arrow
M

Masaki Shiota

Graduate School of Medical Sciences
H指数:47
被引数:6,133

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multicenter prospective observational study to evaluate the clinical utility of rs61094339 SNP Kit in predicting response to intravesical Bacillus Calmette-Guérin therapy for highest-risk non-muscle-invasive bladder cancer: the PRECISE-BCG study

多中心前瞻性观察性研究评估rs61094339 SNP试剂盒在预测高危非肌层浸润性膀胱癌对膀胱内卡介苗治疗的反应中的临床应用价值:PRECISE-BCG研究

2026-08-280
OA
Spatial multi-omics reveal spatially coordinated cholesterol metabolic programs in castration-resistant prostate cancer

空间多组学揭示去势抵抗性前列腺癌中空间协调的胆固醇代谢程序

2026-08-280
OA
Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401

局限性挽救性放疗在根治性前列腺切除术后疗效的病理学预测因素:JCOG0401研究的中心回顾

Cancers
IF4.4
2026-06-080
OAAI
GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer

多中心前瞻性研究中关于镭-223在骨转移性去势抵抗性前列腺癌的GWAS

2026-06-020
OAAI
Impact of radium-223 on bone imaging and biochemical markers with and without bone-modifying agents in bone-metastatic castration-resistant prostate cancer: results from the kyucog-1901 study

镭-223对骨转移性去势抵抗性前列腺癌中骨显像和生化标志物的影响:有无骨修饰剂时的结果——基于KYUCOG-1901研究

2026-02-100
OAAI
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study

年龄 ≥ 75岁前列腺癌患者的主动监测: 国际前列腺癌研究: 主动监测 (PRIAS)-日本研究

2026-01-290
PRE
Comparison of first-line immuno-oncology combinations with molecular targeted therapy in patients with advanced renal cell carcinoma undergoing hemodialysis: a real-world multicenter retrospective study

比较一线免疫肿瘤联合疗法与分子靶向疗法在行血液透析的晚期肾细胞癌患者中的疗效:一项真实世界多中心回顾性研究

2025-12-020
PRE
Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen project

基因组改变和循环肿瘤DNA在晚期尿路上皮癌患者中的临床意义:日本SCRUM-monstar筛查项目

2025-11-180
OAAI
Impact of Human Development Index Category on Prostate Cancer Characteristics in Asia

人类发展指数类别对亚洲前列腺癌特征的影响

2025-10-010
PRE
Protocol summary of a randomized controlled phase III trial for confirming the superiority of local radiotherapy for prostate cancer patients with high-volume metastasis sensitive to hormonal therapy: the JCOG2011 (HimeRT study)

一项旨在证实内分泌治疗敏感的高体积转移性前列腺癌患者局部放疗优越性的随机对照III期试验方案摘要:JCOG2011(HimeRT研究)。

2025-10-010
PRE
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab

全基因组关联研究(GWAS)鉴定出与接受纳武利尤单抗治疗的晚期肾细胞癌患者严重不良事件及疗效相关的单核苷酸多态性(SNP)。

2025-09-240
OAAI